Literature DB >> 21730884

Cisplatin ototoxicity affecting cochlear implant benefit.

Michael S Harris1, Jaimie L Gilbert, Kelly A Lormore, Swapna A Musunuru, Michael H Fritsch.   

Abstract

OBJECTIVE: Report a case of loss of cochlear implant benefit after cisplatin therapy to treat osteosarcoma. Examine the implications for the loci of cisplatin-associated cochleotoxicity. STUDY
DESIGN: Retrospective case review.
SETTING: Tertiary referral center. PATIENTS: Single case study. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Cochlear implant programming levels.
RESULTS: Increase in cochlear implant programming T- and C-levels after cisplatin therapy.
CONCLUSION: Cisplatin therapy likely affects spiral ganglion cells. It seems that auditory cells other than outer hair cells in the organ of Corti are affected by cisplatin because the hearing sensitivity of this patient with nonfunctioning outer hair cells declined after receiving chemotherapy. Implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21730884      PMCID: PMC3144856          DOI: 10.1097/MAO.0b013e3182255893

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  21 in total

Review 1.  Mechanisms of cisplatin-induced ototoxicity and prevention.

Authors:  Leonard P Rybak; Craig A Whitworth; Debashree Mukherjea; Vickram Ramkumar
Journal:  Hear Res       Date:  2006-11-17       Impact factor: 3.208

2.  Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma.

Authors:  Brian H Kushner; Amy Budnick; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Journal:  Cancer       Date:  2006-07-15       Impact factor: 6.860

3.  The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study.

Authors:  Marjolein W M van Ruijven; John C M J de Groot; Sjaak F L Klis; Guido F Smoorenburg
Journal:  Hear Res       Date:  2005-07       Impact factor: 3.208

4.  Role of reactive radicals in degeneration of the auditory system of mice following cisplatin treatment.

Authors:  Ji Eun Lee; Takayuki Nakagawa; Tae Soo Kim; Tsuyoshi Endo; Atsushi Shiga; Fukuichiro Iguchi; Sang Heun Lee; Juichi Ito
Journal:  Acta Otolaryngol       Date:  2004-12       Impact factor: 1.494

5.  Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity.

Authors:  Hyung-Jin Kim; Jeong-Han Lee; Se-Jin Kim; Gi Su Oh; Hae-Dalma Moon; Kang-Beom Kwon; Channy Park; Byung Hyun Park; Ho-Kyun Lee; Sang-Young Chung; Raekil Park; Hong-Seob So
Journal:  J Neurosci       Date:  2010-03-17       Impact factor: 6.167

Review 6.  Mechanisms of cisplatin ototoxicity and progress in otoprotection.

Authors:  Leonard P Rybak
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2007-10       Impact factor: 2.064

Review 7.  Cisplatin ototoxicity and protection: clinical and experimental studies.

Authors:  Leonard P Rybak; Debashree Mukherjea; Sarvesh Jajoo; Vickram Ramkumar
Journal:  Tohoku J Exp Med       Date:  2009-11       Impact factor: 1.848

8.  Ototoxicity from cisplatin therapy in childhood cancer.

Authors:  Patrícia P Coradini; Luciana Cigana; Simone G A Selistre; Letícia S Rosito; Algemir L Brunetto
Journal:  J Pediatr Hematol Oncol       Date:  2007-06       Impact factor: 1.289

9.  The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner ear.

Authors:  J R García-Berrocal; J Nevado; R Ramírez-Camacho; R Sanz; J A González-García; C Sánchez-Rodríguez; B Cantos; P España; J M Verdaguer; A Trinidad Cabezas
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

10.  Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activity.

Authors:  Theresa M Harned; Ondrej Kalous; Alexander Neuwelt; Jason Loera; Lingyun Ji; Peter Iovine; Richard Sposto; Edward A Neuwelt; C Patrick Reynolds
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

View more
  6 in total

1.  Challenges of Hearing Rehabilitation after Radiation and Chemotherapy.

Authors:  Marc-Elie Nader; Paul W Gidley
Journal:  J Neurol Surg B Skull Base       Date:  2019-02-04

Review 2.  Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

Authors:  Jochen Schacht; Andra E Talaska; Leonard P Rybak
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

3.  Cochlear Implantation for Profound Hearing Loss After Multimodal Treatment for Neuroblastoma in Children.

Authors:  Nam-Gyu Ryu; Il Joon Moon; Young Soo Chang; Byoung Kil Kim; Won-Ho Chung; Yang-Sun Cho; Sung Hwa Hong
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-11-10       Impact factor: 3.372

4.  Ursolic acid protects against cisplatin‑induced ototoxicity by inhibiting oxidative stress and TRPV1‑mediated Ca2+‑signaling.

Authors:  Yang Di; Tao Xu; Yuan Tian; Tingting Ma; Donghao Qu; Yan Wang; Yuhan Lin; Dongyan Bao; Li Yu; Shuangyue Liu; Aimei Wang
Journal:  Int J Mol Med       Date:  2020-06-04       Impact factor: 4.101

5.  Restoring microenvironmental redox and pH homeostasis inhibits neoplastic cell growth and migration: therapeutic efficacy of esomeprazole plus sulfasalazine on 3-MCA-induced sarcoma.

Authors:  Enrica Balza; Patrizia Castellani; Paola Sanchez Moreno; Patrizia Piccioli; Iria Medraño-Fernandez; Claudia Semino; Anna Rubartelli
Journal:  Oncotarget       Date:  2017-06-27

Review 6.  Mechanism and Prevention of Spiral Ganglion Neuron Degeneration in the Cochlea.

Authors:  Li Zhang; Sen Chen; Yu Sun
Journal:  Front Cell Neurosci       Date:  2022-01-05       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.